Equator Therapeutics YC 申请

Winter 2020Active

Equator Therapeutics 在 Winter 2020 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2020
行业: HealthcareTherapeutics
团队规模: 2
状态: Active
已发布: 2020

创始人

Liliya KhasinFounder
Yuriy KirichokFounder
Jonah SinickFounder

Equator Therapeutics 做什么

We are developing a drug to increase metabolism and burn calories without exercise. Obesity and type 2 diabetes have reached epidemic proportions. There are 2.2B overweight people and 500M people with type 2 diabetes worldwide, and these numbers increase drastically every year. Existing drugs are not effective enough to reverse the trend. Our drug can solve this problem, because it addresses the root cause of metabolic disorders - the imbalance between caloric intake and expenditure. Our drug will target mitochondria - the powerhouse of the cell - to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.

Equator Therapeutics 的 YC 申请，重建版

Y Combinator 申请

Equator Therapeutics，Winter 2020 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Equator Therapeutics

Describe what your company does in 50 characters or less.

Drug to burn calories and increase metabolism

What is your company going to make? Please describe your product and what it does or will do.

We are developing a drug that activates a natural protein in mitochondria to generate heat, burning calories and increasing metabolism without exercise. Our approach targets the root cause of obesity and type 2 diabetes by shifting the balance between calorie intake and expenditure through mitochondrial heat production, overcoming the side effects of previous methods.

Where do you live now, and where would the company be based after YC?

We live in San Francisco and plan to keep the company based here after YC.

Explain your decision regarding location.

San Francisco is where the team already lives and works, giving us access to biotech talent and resources critical for developing a therapeutic drug.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Equator Therapeutics 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Equator Therapeutics 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Equator Therapeutics 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Equator Therapeutics 是哪个 YC 批次的？

Equator Therapeutics 是 Y Combinator Winter 2020 批次的成员。

谁创立了 Equator Therapeutics？

Equator Therapeutics 由 Liliya Khasin, Yuriy Kirichok, Jonah Sinick 创立。

Equator Therapeutics 做什么？

We are developing a drug to burn calories and increase metabolism…

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Equator Therapeutics 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。